Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...

Patients with Alzheimer's who took a GLP-1 drug improved their memory scores and lost less of their brains.

A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.

Groundbreaking research reveals that long-term use of common drugs for depression, bladder control, and Parkinson’s could be ...

Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate blood sugar and appetite. GLP-1 is primarily secreted from the intestines, ...

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type 2 diabetes. Reading time 2 minutes The case for Ozempic as a dementia ...

Scientists hope to investigate whether common drugs could be used to help fight dementia after ibuprofen and some prescription antibiotics, antivirals and vaccines were associated with a reduced risk ...

Data included more than a million participants to find that Alzheimer's risk was up to 76% lower in these cases.

Some antibiotics, antivirals, vaccinations and anti-inflammatory medications are linked to a reduced risk of dementia, a study shows. The report was published Tuesday in Alzheimer’s & Dementia.

Dozens of breakthrough drug trials, including one using the main ingredient in weight-loss jabs, offer patients “hope” for the treatment and prevention of dementia and Alzheimer’s disease. Some 138 ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...